A new Super Bowl Sunday ad starring legendary NFL players aims to boost prostate cancer awareness. Using humor and famous ...

PSA and Ki-67 tumour markers may identify high-risk metastatic castration-sensitive prostate cancer and inform treatment ...

Unfortunately, you’re not able to donate blood today. Not until you’re cancer-free for at least a year. Just on the outside ...

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

Oxybutynin, a common drug to manage overactive bladder, may help alleviate hot flash symptoms among men receiving androgen deprivation therapy for prostate cancer.

Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration-sensitive prostate cancer (mCSPC) initiating ERLEADA® without docetaxel ...

When an intervention prevents a clean disaster, the way a rabies shot does, sanity shows up: it gets used, it stays cheap, ...

The Novartis Board of Directors proposes a dividend payment of CHF 3.70 per share for 2025, up 5.7% from CHF 3.50 per share in the prior year, representing the 29th consecutive dividend increase since ...

Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +8% (cc1, +8% USD) with core operating income1 up +14% (cc, +12% USD) Sales growth driven by continued strong performance ...